MCMedicalCodingSoftware
D09.3

D09.3: Carcinoma in situ of thyroid and other endocrine glands

Billable / specific codeICD-10-CM

D09.3 is a billable, specific ICD-10-CM code for carcinoma in situ of thyroid and other endocrine glands. It is valid for submission on a claim.

Check D09.3 with the rest of the claim: free scrubber

Excludes1: never code together

These conditions cannot occur together. Billing both on the same encounter is a denial.

  • carcinoma in situ of endocrine pancreas (D01.7)
  • carcinoma in situ of ovary (D07.39)
  • carcinoma in situ of testis (D07.69)

Excludes1 inherited from the categories above D09.3

A category’s note binds every code beneath it.

Written on D09: Carcinoma in situ of other and unspecified sites

  • melanoma in situ (D03.-)

Risk adjustment

No CMS-HCC V28 category: this code does not change a RAF score.

Medicare coverage

D09.3 is named in 15 Medicare coverage policies: 15 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

  • A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
  • A54768Billing and Coding: Cardiac Blood Pool Imaging (Multiple Gated Acquisition Scanning- MUGA, Ventriculography) When Performed in Conjunction with Cardiotoxic Chemotherapy
  • A56580Billing and Coding: Computerized Axial Tomography (CT), Thorax
  • A56695Billing and Coding: Implantable Infusion Pump

Code history

Unchanged in every release from FY2024 to FY2027.

Other codes under D09

ICD-10-CMFY2027· effective October 1, 2026

Loaded directly from the CMS/NCHS ICD-10-CM public-domain release: see data sources and our editorial policy. If this page disagrees with the CMS tabular list, this page is wrong. Reference information for professional coders; not medical or billing advice.